This chart tracks pricing for oral PrEP as tenofovir disoproxil and emtricitabine (TDF/FTC) as compared to generic pricing in low- and middle-income countries (LMICs) since 2005.
- Topics:
- Advocating for Health Equity
Was this content helpful?
Tell us how we can improve the content.
Was this content helpful?
Thank you for your feedback!